Japan’s reimbursement system evaluates wearable medical devices based on clinical efficacy, safety, and cost-effectiveness. MHLW and Chuikyo determine classification and pricing under the NHI system. Wearables must demonstrate measurable health benefits and align with healthcare needs. Innovative wearables offering significant improvements in monitoring or treatment may qualify for premium reimbursement.
